Chemomab appoints Matthew Frankel as CMO & VP Drug Development, effective Nov 14

Chemomab Therapeutics Ltd.

Dr. Frankel will receive annual base salary of $450,000 and bonus potential of 45% of base.
He receives a signing bonus of $200,000, payable in two $100,000 installments within 60 and 120 days.
Granted options to purchase 125,000 ADRs, vesting over four years (25% on first anniversary, remainder monthly).
Frankel previously led clinical development at Boehringer Ingelheim, Novartis, Sandoz, and Reata Pharmaceuticals.
Interim CMO Dave Weiner will stay on as Senior Advisor.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Matthew B. Frankel

Chief Medical Officer & VP, Drug Development

CMMB · Chemomab Therapeutics Ltd.

Effective: 2022-11-14
Filed: November 14, 2022, 6:59 PM ET

On November 14, 2022, Chemomab Therapeutics Ltd. (the “Company”) announced the appointment of Dr. Matthew B. Frankel as Chief Medical Officer & VP, Drug Development of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Matthew B. Frankel was appointed as Chief Medical Officer & VP, Drug Development at Chemomab Therapeutics Ltd..

Action: appointed
Role: Chief Medical Officer & VP, Drug Development

Exact text from the filing

On November 14, 2022, Chemomab Therapeutics Ltd. (the “Company”) announced the appointment of Dr. Matthew B. Frankel as Chief Medical Officer & VP, Drug Development of the Company.

View on SEC.gov

Chemomab Therapeutics Ltd. filing history →

Source: SEC EDGAR

accession 0001178913-22-004019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.